Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence.

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

SUTTON L.A. KOSTARELI E. STALIKA E. TSAFTARIS A. ANAGNOSTOPOULOS A. DARZENTAS Nikos ROSENQUIST R. STAMATOPOULOS K.

Year of publication 2013
Type Article in Periodical
Magazine / Source Molecular Medicine
MU Faculty or unit

Central European Institute of Technology

Citation
Web http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769528/
Doi http://dx.doi.org/10.2119/molmed.2013.00042
Field Oncology and hematology
Keywords chronic lymphocytic leukemia; temporal dynamics; IGHV4-34/IGKV2-30
Description Chronic lymphocytic leukemia (CLL) patients assigned to stereotyped subset 4 possess distinctive patterns of intraclonal diversification (ID) within their immunoglobulin (IG) genes. Although highly indicative of an ongoing response to antigen(s), the critical question concerning the precise timing of antigen involvement is unresolved. Hence, we conducted a large-scale longitudinal study of eight subset 4 cases totaling 511 and 398 subcloned IG heavy and kappa sequences. Importantly, we could establish a hierarchical pattern of subclonal evolution, thus revealing which somatic hypermutations were negatively or positively selected. In addition, distinct clusters of subcloned sequences with cluster-specific mutational profiles were observed initially however, at later time points, the minor cluster had often disappeared and hence not been selected. Despite the high intensity of ID, it was remarkable that certain residues remained essentially unaltered. These novel findings strongly support a role for persistent antigen stimulation in the clonal evolution of CLL subset 4.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info